文献速递银屑病与炎症性皮肤病

台湾银屑病患者全因与死因别死亡率:全国性人群研究

All-Cause and Cause-Specific Mortality in Patients with Psoriasis in Taiwan: A Nationwide Population-Based Study.
PubMed 文献 · J Invest Dermatol · 2017-02-28

该研究基于台湾全民健康保险数据库2001–2012年新诊断的80,167例银屑病患者,随访508,505人年共记录7,198例死亡。重症银屑病、早发型银屑病及合并银屑病关节炎患者的全因死亡率标准化死亡比分别为1.53、1.47和1.47;死因别分析中恶性肿瘤和循环系统疾病的绝对与超额死亡风险最高。

要点

  • 重症银屑病全因死亡风险升高,标准化死亡比为1.53(95%CI 1.45-1.60)。
  • 早发型银屑病和合并银屑病关节炎患者全因死亡率标准化死亡比均为1.47。
  • 恶性肿瘤和循环系统疾病是超额死亡风险最高的死因。

核心结论

  • 重症银屑病、早发型银屑病及合并银屑病关节炎患者全因死亡风险更高,恶性肿瘤和循环系统疾病超额死亡风险尤其突出。

研究设计与样本

  • 全国性人群队列研究,纳入2001–2012年台湾全民健康保险数据库中80,167例新诊断银屑病患者,随访508,505人年,死亡信息来自台湾死亡登记库。

主要发现

  • 随访期间共记录7,198例死亡。
  • 重症银屑病标准化死亡比为1.53(95%CI 1.45-1.60)。
  • 早发型银屑病标准化死亡比为1.47(95%CI 1.34-1.61)。
  • 合并银屑病关节炎患者标准化死亡比为1.47(95%CI 1.36-1.58)。
  • 恶性肿瘤绝对死亡风险为每1,000患者年3.6例、超额风险为每1,000患者年1.57例,循环系统疾病分别为每1,000患者年3.0例和1.44例。

临床怎么用

  • 对重症、早发型或合并银屑病关节炎的银屑病患者,应关注全因死亡风险升高。
  • 临床管理中需重视恶性肿瘤和循环系统疾病的筛查与防控。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Asian population-based data evaluating all-cause mortality and cause-specific mortality in patients with psoriasis are limited. This study aimed to evaluate the risk of all-cause mortality (stratified according to onset status, disease severity, and concomitant psoriatic arthritis) and cause-specific mortality in patients with psoriasis. Our study cohort consisted of 80,167 patients with newly diagnosed psoriasis between 2001 and 2012 in the National Health Insurance Database. Vital status and cause of death were ascertained from the National Death Registry of Taiwan. All-cause and cause-specific crude mortality rates and standardized mortality ratios were estimated. A total of 7,198 deaths were identified during the follow-up period (508,505 person-years). The standardized mortality ratios were 1.53 for severe psoriasis (95% confidence interval = 1.45-1.60), 1.47 for early-onset psoriasis (95% confidence interval = 1.34-1.61), and 1.47 for patients with psoriatic arthritis (95% confidence interval = 1.36-1.58). In the cause-specific mortality analysis, the absolute and excess risks of death were highest for malignancies (3.6 and 1.57 deaths per 1,000 patient-years, respectively) and circulatory system diseases (3.0 and 1.44 deaths per 1,000 patient-years, respectively). Patients with severe psoriasis, early-onset psoriasis, and psoriatic arthritis had higher all-cause mortality risks. In particular, patients with psoriasis had higher excess risks of mortality from malignancies and circulatory system diseases.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Lee MS, Yeh YC, Chang YT, et al. All-Cause and Cause-Specific Mortality in Patients with Psoriasis in Taiwan: A Nationwide Population-Based Study. J Invest Dermatol. 2017. PMID: 28257796. doi:10.1016/j.jid.2017.01.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。